Closing the Gap: Evaluating the Safety and Effectiveness of Diabetic Ketoacidosis Nomograms
- 14 November 2025
- journal article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 60 (6) , 537-545
Abstract
Background: Diabetic ketoacidosis (DKA) is a severe complication of diabetes mellitus requiring insulin. However, there is no consensus on insulin infusion titration strategies, resulting in varied nomograms and potentially suboptimal management. Limited comparative data on insulin nomograms underscore the need for a standardized, evidence-based approach. Objective: The purpose of this study is to evaluate the safety and effectiveness of 3 DKA nomograms. Methods: This multicenter, retrospective observational study included adult patients with confirmed DKA treated with IV insulin for ≥3 hours. Each site used a different variable-rate nomogram: variable rate weight-adjusted IV insulin infusion with no bolus (VR-W-NB), variable-rate IV insulin infusion with bolus (VR-B) or variable-rate IV insulin infusion with no bolus (VR-NB). The primary endpoint was the incidence of hypoglycemia (P < 0.01). After controlling for confounding factors, hypoglycemia remained the highest in the VR-W-NB (odds ratio [OR] = 6.2, 95% confidence interval [CI] = 2.5-15.3, P < 0.01) and VR-B (OR = 5, 95% CI = 2.1-12.1, P < 0.01) cohorts compared with the VR-NB cohort. Diabetic ketoacidosis resolution was significantly shorter in patients receiving VR-W-NB (median of 9.7 hours, interquartile range [IQR] = 5.6-16.9) compared with those receiving VR-B (12.7 hours, IQR = 9.2-25) and VR-NB (16.1 hours, IQR = 10-24.5). DKA recurrence was higher in those treated with VR-B (19.7%) compared with those treated with VR-W-NB (7%) and VR-NB (15.5%) ( P = 0.02). Conclusion and relevance: The VR-W-NB was associated with a higher incidence of hypoglycemia and faster DKA resolution compared with VR-B and VR-NB. These findings support the need for prospective studies to define optimal insulin strategies that improve safety, effectiveness, and resource utilization.Keywords
This publication has 16 references indexed in Scilit:
- Management of diabetic ketoacidosis in adult inpatients: A retrospective analysis of rates of hypoglycaemia with variable‐rate and fixed‐rate intravenous insulin infusion protocolsDiabetic Medicine, 2025
- Hyperglycaemic crises in adults with diabetes: a consensus reportDiabetologia, 2024
- Safety of an Initial Insulin Bolus in the Treatment of Diabetic KetoacidosisJournal of Pharmacy Practice, 2023
- A Comparison of Variable Versus Fixed Insulin Infusion Rate on Resolution of Diabetic KetoacidosisAmerican Journal of Therapeutics, 2023
- Diabetic ketoacidosisDisease-a-Month, 2022
- Fixed-rate insulin for adult diabetic ketoacidosis is associated with more frequent hypoglycaemia than rate-reduction method: a retrospective cohort studyInternational Journal of Pharmacy Practice, 2019
- Transitioning Safely from Intravenous to Subcutaneous InsulinCurrent Diabetes Reports, 2015
- Utility of Initial Bolus Insulin in the Treatment of Diabetic KetoacidosisThe Journal of Emergency Medicine, 2010
- Hyperglycemic Crises in Adult Patients With DiabetesDiabetes Care, 2009
- Is a Priming Dose of Insulin Necessary in a Low-Dose Insulin Protocol for the Treatment of Diabetic Ketoacidosis?Diabetes Care, 2008